Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells.
Argenziano M, Lombardi C, Ferrara B, Trotta F, Caldera F, Blangetti M, Koltai H, Kapulnik Y, Yarden R, Gigliotti L, Dianzani U, Dianzani C, Prandi C, Cavalli R. Argenziano M, et al. Among authors: yarden r. Oncotarget. 2018 Nov 9;9(88):35813-35829. doi: 10.18632/oncotarget.26287. eCollection 2018 Nov 9. Oncotarget. 2018. PMID: 30533197 Free PMC article.
Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.
Pollock CB, McDonough S, Wang VS, Lee H, Ringer L, Li X, Prandi C, Lee RJ, Feldman AS, Koltai H, Kapulnik Y, Rodriguez OC, Schlegel R, Albanese C, Yarden RI. Pollock CB, et al. Among authors: yarden ri. Oncotarget. 2014 Mar 30;5(6):1683-98. doi: 10.18632/oncotarget.1849. Oncotarget. 2014. PMID: 24742967 Free PMC article.
Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair.
Croglio MP, Haake JM, Ryan CP, Wang VS, Lapier J, Schlarbaum JP, Dayani Y, Artuso E, Prandi C, Koltai H, Agama K, Pommier Y, Chen Y, Tricoli L, LaRocque JR, Albanese C, Yarden RI. Croglio MP, et al. Among authors: yarden ri. Oncotarget. 2016 Mar 22;7(12):13984-4001. doi: 10.18632/oncotarget.7414. Oncotarget. 2016. PMID: 26910887 Free PMC article.
Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model.
Mayzlish-Gati E, Laufer D, Grivas CF, Shaknof J, Sananes A, Bier A, Ben-Harosh S, Belausov E, Johnson MD, Artuso E, Levi O, Genin O, Prandi C, Khalaila I, Pines M, Yarden RI, Kapulnik Y, Koltai H. Mayzlish-Gati E, et al. Among authors: yarden ri. Cancer Biol Ther. 2015;16(11):1682-8. doi: 10.1080/15384047.2015.1070982. Epub 2015 Jul 20. Cancer Biol Ther. 2015. PMID: 26192476 Free PMC article.
Mechanisms of EGF receptor regulation in breast cancer cells.
Chrysogelos SA, Yarden RI, Lauber AH, Murphy JM. Chrysogelos SA, et al. Among authors: yarden ri. Breast Cancer Res Treat. 1994;31(2-3):227-36. doi: 10.1007/BF00666156. Breast Cancer Res Treat. 1994. PMID: 7881101
Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression.
Hoskins JW, Ibrahim A, Emmanuel MA, Manmiller SM, Wu Y, O'Neill M, Jia J, Collins I, Zhang M, Thomas JV, Rost LM, Das S, Parikh H, Haake JM, Matters GL, Kurtz RC, Bamlet WR, Klein A, Stolzenberg-Solomon R, Wolpin BM, Yarden R, Wang Z, Smith J, Olson SH, Andresson T, Petersen GM, Amundadottir LT. Hoskins JW, et al. Among authors: yarden r. Hum Mol Genet. 2016 Nov 1;25(21):4726-4738. doi: 10.1093/hmg/ddw300. Hum Mol Genet. 2016. PMID: 28172817 Free PMC article.
24 results